Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.

Ladoire S, Penault-Llorca F, Senovilla L, Dalban C, Enot D, Locher C, Prada N, Poirier-Colame V, Chaba K, Arnould L, Ghiringhelli F, Fumoleau P, Spielmann M, Delaloge S, Poillot ML, Arveux P, Goubar A, Andre F, Zitvogel L, Kroemer G.

Autophagy. 2015;11(10):1878-90. doi: 10.1080/15548627.2015.1082022.

2.

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.

Semeraro M, Rusakiewicz S, Minard-Colin V, Delahaye NF, Enot D, Vély F, Marabelle A, Papoular B, Piperoglou C, Ponzoni M, Perri P, Tchirkov A, Matta J, Lapierre V, Shekarian T, Valsesia-Wittmann S, Commo F, Prada N, Poirier-Colame V, Bressac B, Cotteret S, Brugieres L, Farace F, Chaput N, Kroemer G, Valteau-Couanet D, Zitvogel L.

Sci Transl Med. 2015 Apr 15;7(283):283ra55. doi: 10.1126/scitranslmed.aaa2327.

PMID:
25877893
3.

Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin.

Dudek-Perić AM, Ferreira GB, Muchowicz A, Wouters J, Prada N, Martin S, Kiviluoto S, Winiarska M, Boon L, Mathieu C, van den Oord J, Stas M, Gougeon ML, Golab J, Garg AD, Agostinis P.

Cancer Res. 2015 Apr 15;75(8):1603-14. doi: 10.1158/0008-5472.CAN-14-2089. Epub 2015 Mar 11.

4.

Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant.

Mohri H, Prada N, Markowitz M.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):487-94. doi: 10.1097/QAI.0000000000000524.

5.

A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals.

Markowitz M, Evering TH, Garmon D, Caskey M, La Mar M, Rodriguez K, Sahi V, Palmer S, Prada N, Mohri H.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):140-7. doi: 10.1097/QAI.0000000000000111.

6.

Current trends of anticancer immunochemotherapy.

Vacchelli E, Prada N, Kepp O, Galluzzi L.

Oncoimmunology. 2013 Jun 1;2(6):e25396. Epub 2013 Jun 13. No abstract available.

7.

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.

Yamazaki T, Hannani D, Poirier-Colame V, Ladoire S, Locher C, Sistigu A, Prada N, Adjemian S, Catani JP, Freudenberg M, Galanos C, André F, Kroemer G, Zitvogel L.

Cell Death Differ. 2014 Jan;21(1):69-78. doi: 10.1038/cdd.2013.72. Epub 2013 Jun 28.

8.

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.

Prada N, Antoni G, Commo F, Rusakiewicz S, Semeraro M, Boufassa F, Lambotte O, Meyer L, Gougeon ML, Zitvogel L.

Oncoimmunology. 2013 Mar 1;2(3):e23472.

9.

Clinical results of XMR-assisted percutaneous transforaminal endoscopic lumbar discectomy.

Choi G, Modi HN, Prada N, Ahn TJ, Myung SH, Gang MS, Lee SH.

J Orthop Surg Res. 2013 May 25;8:14. doi: 10.1186/1749-799X-8-14.

10.

Percutaneous endoscopic lumbar herniectomy for high-grade down-migrated L4-L5 disc through an L5-S1 interlaminar approach: a technical note.

Choi G, Prada N, Modi HN, Vasavada NB, Kim JS, Lee SH.

Minim Invasive Neurosurg. 2010 Jun;53(3):147-52. doi: 10.1055/s-0030-1254145. Epub 2010 Aug 31.

PMID:
20809458
11.

Transcorporeal tunnel approach for unilateral cervical radiculopathy: a 2-year follow-up review and results.

Choi G, Arbatti NJ, Modi HN, Prada N, Kim JS, Kim HJ, Myung SH, Lee SH.

Minim Invasive Neurosurg. 2010 Jun;53(3):127-31. doi: 10.1055/s-0030-1249681. Epub 2010 Aug 31.

PMID:
20809454
12.

Novel integrase inhibitors for HIV.

Prada N, Markowitz M.

Expert Opin Investig Drugs. 2010 Sep;19(9):1087-98. doi: 10.1517/13543784.2010.501078. Review.

PMID:
20707594
13.

Risk of developing seizure after percutaneous endoscopic lumbar discectomy.

Choi G, Kang HY, Modi HN, Prada N, Nicolau RJ, Joh JY, Pan WJ, Lee SH.

J Spinal Disord Tech. 2011 Apr;24(2):83-92. doi: 10.1097/BSD.0b013e3181ddf124.

PMID:
20625320
14.

Modified transcorporeal anterior cervical microforaminotomy assisted by O-arm-based navigation: a technical case report.

Kim JS, Eun SS, Prada N, Choi G, Lee SH.

Eur Spine J. 2011 Jul;20 Suppl 2:S147-52. doi: 10.1007/s00586-010-1454-2. Epub 2010 May 21.

15.

Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors.

Low A, Prada N, Topper M, Vaida F, Castor D, Mohri H, Hazuda D, Muesing M, Markowitz M.

Antimicrob Agents Chemother. 2009 Oct;53(10):4275-82. doi: 10.1128/AAC.00397-09. Epub 2009 Aug 3.

16.

Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course.

Prada N, Davis B, Jean-Pierre P, La Roche M, Duh FM, Carrington M, Poles M, Mehandru S, Mohri H, Markowitz M.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):117-22. doi: 10.1097/QAI.0b013e3181869a9b.

17.

Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome.

Roat E, Prada N, Lugli E, Nasi M, Ferraresi R, Troiano L, Giovenzana C, Pinti M, Biagioni O, Mariotti M, Di Iorio A, Consolo U, Balli F, Cossarizza A.

Rejuvenation Res. 2008 Jun;11(3):573-83. doi: 10.1089/rej.2007.0648.

PMID:
18386990
18.

Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome.

Roat E, Prada N, Ferraresi R, Giovenzana C, Nasi M, Troiano L, Pinti M, Nemes E, Lugli E, Biagioni O, Mariotti M, Ciacci L, Consolo U, Balli F, Cossarizza A.

FEBS Lett. 2007 Feb 6;581(3):521-5. Epub 2007 Jan 17.

19.

Characterization of cells with different mitochondrial membrane potential during apoptosis.

Lugli E, Troiano L, Ferraresi R, Roat E, Prada N, Nasi M, Pinti M, Cooper EL, Cossarizza A.

Cytometry A. 2005 Nov;68(1):28-35.

20.

MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection.

Lugli E, Pinti M, Nasi M, Troiano L, Prada N, Mussini C, Borghi V, Esposito R, Cossarizza A.

Int J Immunogenet. 2005 Oct;32(5):269-71.

PMID:
16164692
21.

Changes in mitochondrial RNA production in cells treated with nucleoside analogues.

Galluzzi L, Pinti M, Troiano L, Prada N, Nasi M, Ferraresi R, Salomoni P, Mussini C, Cossarizza A.

Antivir Ther. 2005;10(1):191-5.

PMID:
15751778
22.

Direct analysis of thymic function in children with Down's syndrome.

Prada N, Nasi M, Troiano L, Roat E, Pinti M, Nemes E, Lugli E, Ferraresi R, Ciacci L, Bertoni D, Biagioni O, Gibertoni M, Cornia C, Meschiari L, Gramazio E, Mariotti M, Consolo U, Balli F, Cossarizza A.

Immun Ageing. 2005 Feb 16;2:4. doi: 10.1186/1742-4933-2-4. eCollection 2005.

23.

Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).

Magdolen V, Bürgle M, de Prada NA, Schmiedeberg N, Riemer C, Schroeck F, Kellermann J, Degitz K, Wilhelm OG, Schmitt M, Kessler H.

Biol Chem. 2001 Aug;382(8):1197-205.

PMID:
11592401
24.

Surgical treatment of submucous cleft palate: a comparative trial of two modalities for palatal closure.

Ysunza A, Pamplona MC, Mendoza M, Molina F, Martinez P, García-Velasco M, Prada N.

Plast Reconstr Surg. 2001 Jan;107(1):9-14.

PMID:
11176594
25.

Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptides.

Muehlenweg B, Guthaus E, de Prada NA, Schmitt M, Schmiedeberg N, Kotzsch M, Creutzburg S, Kramer MD, Kessler H, Wilhelm OG, Magdolen V.

Thromb Res. 2000 Apr 1;98(1):73-81.

PMID:
10706935
26.

[Action of karyoklastic substances on regeneration in amphibians].

PRADA N.

Tumori. 1950 Mar-Apr;24(2):66-74. Undetermined Language. No abstract available.

PMID:
15424948

Supplemental Content

Support Center